Strategize, model, decide.
A2-Ai is a premier full-service consultancy run by leaders who put science and patients first, with a focus on providing true value to our clients. Our scientists and technologists are world-class subject matter experts with decades of combined experience.
See how we leverage data-driven methods for selecting your drug dosage and treatment schedules.
Learn more
Let's get you moving faster than ever
Clinical Pharmacology
Pharmacometrics
Preclinical Support
Technology
A science-first approach
At A2-Ai, we commit to the success of our clients' programs as if they are our own. We engage early and move your assets as quickly as possible toward your corporate goals. For every project, our approach to finding solutions is always customized, personalized, and collaborative. We tailor the resources needed to support your assets and guarantee industry-leading quality standards.
Early Phase
Our early phase support includes assessment of IND packages, First in Patient dose selection, dose escalation strategy, and dose optimization support of EOP1 and EOP2 Type C meetings with the FDA or EMA. Our staff has experience across multiple therapeutic areas such as inflammation, diabetes, CNS and virology, with specific expertise in oncology.
Late Phase
Our approach is to share our extensive experience in late phase drug development with you, which includes many successful NDA/BLAs across our staff. For late phase projects, we perform all necessary quantitative pharmacometrics (PmX) analyses and prepare reports for your submission (Population PK, ER for safety, ER for efficacy, and ER for QT). We also provide medical writing services such as CSR writing and submissions document writing for SCP and SBS.